AL amyloidosis - light chains and molecular characteristics determine pathogenesis and prognosis

Anja Seckinger

Presentation information

Oral Session

Oral Session 2-9D Multiple Myeloma: Clinical (Prognosis/Biomarker/Salvage Therapy)

Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.9 (Tokyo International Forum, 4F G402)

Chair: Chikako Ohwada (Department of Hematology, Chiba University Hospital)

[OS2-9D-5] AL amyloidosis - light chains and molecular characteristics determine pathogenesis and prognosis

Anja Seckinger¹, Ute Hegenbart¹, Susanne Beck¹, Martina Emde¹, Tilmann Bochtler¹, Christoph Kimmich¹, Carsten Mueller-Tidow¹, Anna Jauch², Stefan Schoenland¹, Dirk Hose¹ (1.Heidelberg University Hospital, Heidelberg, BW, Federal Republic of Germany, 2.Heidelberg University, Heidelberg, BW, Federal Republic of Germany)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.